The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Can we treat Alzheimer’s by ‘seeding our guts’ with beneficial bateria?

| | September 27, 2019

In a study published in the Journal of Experimental Medicine earlier this year, microbiologist Hemraj Dodiya of the University of Chicago and colleagues sought to determine whether bacteria in the gut could influence the progression of Alzheimer’s disease.

In their study, Dodiya and his colleagues found evidence that bacteria can influence Alzheimer’s symptoms in male mice. They tested the effects of microbes in the gut on amyloid beta and microglia in the brain using a line of transgenic mice developed specifically to have extra amyloid precursor proteins.

Although we’re not likely to start giving long-term antibiotics to treat Alzheimer’s disease, the finding that antibiotics reduced Alzheimer’s symptoms in male mice can now be harnessed to better understand timing and influence of gut bacteria in Alzheimer’s disease. Is there a window of time in which bacterial function is critical? In the future, will we be able to seed our guts with specific bacteria to reduce Alzheimer’s symptoms? More studies are needed to understand these processes and extend the lessons learned in mouse models to human disease.

Related article:  Viewpoint: We can't fight sexism by denying the science behind male-female brain differences

Read full, original post: The Gut Microbiome Could Speed Up the Progression of Alzheimer’s Disease

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend